Document Detail


An unusual site of presentation for Hodgkin's disease in the middle ear.
MedLine Citation:
PMID:  3784557     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We are presenting a case history of a patient with advanced Hodgkin's disease, who had secondary involvement of his middle ear. To our knowledge this is the first case report of such clinical presentation where radiation therapy was of good help for bringing about symptomatic relief. Possible routes of spread are discussed and the literature is reviewed.
Authors:
M Zahra; F Tewfik
Related Documents :
15249857 - Histopathology of cutaneous amebiasis.
15027517 - Kaposi's varicelliform eruption: a case report and review of the literature.
9609987 - Pretibial myxedema with graves' disease: a case report and review of japanese literature.
1117747 - Tricuspid atresia with christmas disease (hemophilia b). report of a case.
6700547 - Rebound thymic hyperplasia in a child with cancer.
9148137 - Rubella and congenital rubella syndrome--united states, 1994-1997.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of surgical oncology     Volume:  33     ISSN:  0022-4790     ISO Abbreviation:  J Surg Oncol     Publication Date:  1986 Dec 
Date Detail:
Created Date:  1987-01-09     Completed Date:  1987-01-09     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0222643     Medline TA:  J Surg Oncol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  227-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Ear Neoplasms / radiography*,  radiotherapy
Ear, Middle / radiography*
Follow-Up Studies
Hodgkin Disease / radiography*,  radiotherapy
Humans
Male
Tomography, X-Ray Computed

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Giant basal cell carcinoma with metastases and myelophthisic anemia.
Next Document:  Interferon-beta treatment of metastatic prostate cancer.